title: Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia.
abstract: Cyclic neutropenia (CN) is a congenital hematopoietic disorder characterized by remarkably regular oscillations of blood neutrophils from near normal to extremely low levels at 21-day intervals. Recurring episodes of severe neutropenia lead to repetitive and sometimes life-threatening infections. To investigate the cellular mechanism of CN, the ultrastructure and the proliferative and survival characteristics of bone marrow-derived CD34(+) early progenitors, CD33(+)/CD34(-) myeloid progenitors, and CD15(+) neutrophil precursors from CN patients and healthy volunteers were studied. The ultrastructural studies showed profound apoptotic features in bone marrow progenitor cells in CN. Colony-forming assays demonstrated a 75% decrease in the number of early myeloid-committed colonies compared with controls. Long-term culture-initiating cell assays demonstrated a 6-fold increase in production of primitive progenitor cells in CN. To determine whether accelerated apoptosis might account for the underproduction of myeloid progenitors, the hematopoietic subpopulations were labeled with fluorescein isothiocyanate-annexin V and analyzed by flow cytometry. Short-term culture of CN cells resulted in apoptosis of approximately 65% of CD34(+) cells, 80% of CD33(+)/CD34(-) cells, and more than 70% of CD15(+) cells, as compared with 20%, 7%, and 15% apoptosis in respective control subpopulations. Evidence of accelerated apoptosis of bone marrow progenitor cells was observed in all 8 patients participating in the study, regardless of the stage in the CN cycle in which bone marrow aspirations were obtained. Granulocyte colony-stimulating factor therapy of CN patients significantly improved survival of bone marrow progenitor cells. These data indicate that ineffective production of neutrophils is due to accelerated apoptosis of bone marrow myeloid progenitor cells in CN.
authors.affiliation: Departments of Medicine and Pathology, University of Washington School of Medicine, Seattle, WA 98195-6422, USA.
authors.forename: A A
authors.initials: AA
authors.lastname: Aprikyan
authors.forename: W C
authors.initials: WC
authors.lastname: Liles
authors.forename: E
authors.initials: E
authors.lastname: Rodger
authors.forename: M
authors.initials: M
authors.lastname: Jonas
authors.forename: E Y
authors.initials: EY
authors.lastname: Chi
authors.forename: D C
authors.initials: DC
authors.lastname: Dale
mesh_terms: D017304:Annexin A5 / Q000378:metabolism; D018952:Antigens, CD34 / Q000502:physiology; D017209:Apoptosis / Q000187:drug effects; D001854:Bone Marrow Cells / Q000473:pathology*; D018929:Cell Culture Techniques; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000502:physiology; D003114:Colony-Forming Units Assay; D005192:Family Health; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000473:pathology*; D006801:Humans; D008854:Microscopy, Electron; D023461:Myeloid Progenitor Cells / Q000473:pathology; D009503:Neutropenia / Q000151:congenital / Q000209:etiology* / Q000473:pathology; D009504:Neutrophils / Q000473:pathology; D010507:Periodicity
chemical_list: D017304:Annexin A5; D018952:Antigens, CD34; D016179:Granulocyte Colony-Stimulating Factor